4,5,6,7-tetrahydro-1H-indazole-3-carboxylic acid (1p-tolyl-meth-(E)-ylidene)hydrazide,
suprafenacine,
(E)-N'-(4-methylbenzylidene)-4,5,6,7-tetrahydro-1H-indazole-3-carbohydrazide,
N'-[(E)-(4-methylphenyl)methylidene]-4,5,6,7-tetrahydro-1H-indazole-3-carbohydrazide,
1477482-50-0,
Suprafenacine,
AC1OAN3R,
MLS000768980,
CHEMBL3196518,
STK109120,
AKOS001632480,
SMR000433714,
ST022241,
SR-01000109069,
SR-01000109069-1,
4,5,6,7-Tetrahydro-1H-indazole-3-carboxylic acid [1-p-tolyl-meth-(E)-ylidene]-hydrazide,
N'-[(1E)-(4-methylphenyl)methylene]-4,5,6,7-tetrahydro-1H-indazole-3-carbohydrazide,
N-[(1E)-2-(4-methylphenyl)-1-azavinyl]-1H-4,5,6,7-tetrahydroindazol-3-ylcarbox amide,
N-[(E)-(4-methylphenyl)methylideneamino]-4,5,6,7-tetrahydro-1H-indazole-3-carboxamide,
SRF,
C16H18N4O,
ZINC01740483,
CID6861947,